Total Laparoscopic vs Open Pancreaticoduodenectomy for the Treatment of Periampullary Adenocarcinomas
1 other identifier
interventional
40
1 country
1
Brief Summary
Laparoscopic pancreaticoduodenectomy (LPD), a surgical option for nonpancreatic periampullary adenocarcinoma (NPPA), is a complex procedure that has become increasing popular. However, there is no consensus as to whether this technique should be performed routinely. Our aim was to evaluate the outcomes of LPD compared with open pancreaticoduodenectomy (OPD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2025
CompletedFirst Submitted
Initial submission to the registry
December 7, 2025
CompletedFirst Posted
Study publicly available on registry
February 4, 2026
CompletedFebruary 23, 2026
December 1, 2025
2 years
December 7, 2025
February 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence of pancreatic fistula after laparoscopic pancreaticoduodenectomy in comparison to open surgery
Laparoscopic pancreaticoduodenectomy is a complex procedure that has become increasing popular. However, there is no consensus as to whether this technique should be performed routinely. Our aim was to evaluate the outcomes of Laparoscopic pancreaticoduodenectomy compared with open pancreaticoduodenectomy.
in 2 years between 2023 - 2025
Study Arms (2)
conventional open pancreaticoduedectomy
ACTIVE COMPARATOR15 patients underwent conventional open pancreaticoduedenctomy
Total laparoscopic pancreaticoduedectomy
ACTIVE COMPARATOR15 patients underwent total laparoscopic pancreaticoduedectomy
Interventions
Fifteen patients in Group A had a total laparoscopic pancreaticoduedectomy.
Fifteen patients in Group A had a traditional open pancreaticoduedectomy.
Eligibility Criteria
You may qualify if:
- Body mass index \<28.0 kg/m2.
- Ampullary tumors, duodenal tumors restricted to the second part of the duodenum, or lower common bile duct tumors.
- Carefully confirmed resectability of the tumors based on preoperative radiology conducted by experienced radiologists and surgeons.
You may not qualify if:
- Patients with \>180 degrees superior mesenteric artery encasement
- Any celiac abutment.
- Unreconstructable superior mesenteric vein/portal occlusion" Aortic invasion or encasement.
- A history of previous upper abdominal surgery.
- Tumors extending to the uncinate.
- Severe cardiorespiratory comorbidities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Theodor Bilharz Research Institute
Giza, Egypt
Related Publications (1)
Paniccia A, Schulick RD, Edil BH. Total Laparoscopic Pancreaticoduodenectomy: A Single-Institutional Experience. Ann Surg Oncol. 2015 Dec;22(13):4380-1. doi: 10.1245/s10434-015-4450-2. Epub 2015 Apr 18.
PMID: 25893407RESULT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of general surgery
Study Record Dates
First Submitted
December 7, 2025
First Posted
February 4, 2026
Study Start
August 5, 2023
Primary Completion
August 5, 2025
Study Completion
October 5, 2025
Last Updated
February 23, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share